Drug recall: Voluntary nationwide recall: Digoxin

Sep. 2023Pharmacy Updates
"Please make time to listen to this on-demand, CME-accredited webinar on intimate partner violence (IPV)—a global health issue that affects physical and mental health and well-being. Judy C. Chang, MD, MPH, who has dedicated much of her career to sharing strategies and tactics around IPV prevention and interventions, discusses a range of topics around this issue during the webinar.
What the webinar will cover
  • Overview of intimate partner violence (IPV)
  • Impact of IPV on women’s health
  • Lessons learned from the COVID-19 pandemic
  • How we can help women experiencing IPV
Presenter:
Judy C. Chang, MD, MPH
Associate Professor
Departments of Obstetrics, Gynecology and Reproductive Sciences and General Internal Medicine
Assistant Dean of Medical Student Research University of Pittsburgh School of Medicine

Watch now

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. Provider is responsible for verifying CME eligibility."

Recent Announcements

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices

October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update

Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.
Sep. 2025Pharmacy Updates

Biosimilar Medication Formulary Updates

Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
Sep. 2025Pharmacy Updates